These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Fielding AK Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039 [TBL] [Abstract][Full Text] [Related]
3. [Outcomes of haplotype allogeneic hematopoietic stem cell transplantation in 17 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]. Zhou J; Zhou H; Zhang R; Wu D Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):170-2. PubMed ID: 24606664 [No Abstract] [Full Text] [Related]
4. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission]. Takeuchi J Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763 [No Abstract] [Full Text] [Related]
5. Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Shi HX; Han W; Zhan XH; Wang Y; Zhao T; Huang XJ Chin Med J (Engl); 2011 Jan; 124(2):246-52. PubMed ID: 21362375 [TBL] [Abstract][Full Text] [Related]
7. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
8. [Treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia]. Yanada M Nihon Rinsho; 2007 Jan; 65 Suppl 1():479-82. PubMed ID: 17474451 [No Abstract] [Full Text] [Related]
9. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome. Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance. Ottmann O Lancet Haematol; 2018 Dec; 5(12):e606-e607. PubMed ID: 30501865 [No Abstract] [Full Text] [Related]
12. [Chemotherapy and hematopoietic stem cell transplantation for acute lymphoblastic leukemia]. Kanda Y Nihon Rinsho; 2012 Apr; 70 Suppl 2():447-55. PubMed ID: 23133998 [No Abstract] [Full Text] [Related]
13. Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Peters SO; Stockschläder M; Hegewisch-Becker S; Krüger W; Weh HJ; Hossfeld DK; Zander AR Bone Marrow Transplant; 1995 May; 15(5):783-4. PubMed ID: 7670406 [TBL] [Abstract][Full Text] [Related]
14. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. Rives S; Estella J; Gómez P; López-Duarte M; de Miguel PG; Verdeguer A; Moreno MJ; Vivanco JL; Couselo JM; Fernández-Delgado R; Maldonado M; Tasso M; López-Ibor B; Lendínez F; López-Almaraz R; Uriz J; Melo M; Fernández-Teijeiro A; Rodríguez I; Badell I Br J Haematol; 2011 Sep; 154(5):600-11. PubMed ID: 21707583 [TBL] [Abstract][Full Text] [Related]
15. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia. Ganzel C; Kharit M; Duksin C; Rowe JM Haematologica; 2018 Oct; 103(10):e489-e490. PubMed ID: 29954929 [No Abstract] [Full Text] [Related]
16. Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Yamamoto M; Hori T; Igarashi K; Shimada H; Tsutsumi H Pediatr Int; 2018 Jan; 60(1):85-87. PubMed ID: 29356285 [No Abstract] [Full Text] [Related]
17. [Philadelphia chromosome (BCR/ABL)--positive acute lymphoblastic leukemia: clinical characteristics and prognostic analysis for the effective therapeutic strategy]. Nagai K; Hayashibara T; Imanishi D; Honda S; Mine M; Kuriyama K; Asanaga M Rinsho Ketsueki; 1997 May; 38(5):414-21. PubMed ID: 9194386 [No Abstract] [Full Text] [Related]
18. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL Biol Blood Marrow Transplant; 2006 Jan; 12(1):1-30. PubMed ID: 16399566 [TBL] [Abstract][Full Text] [Related]
19. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia. Shin HJ; Chung JS; Cho GJ Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662 [No Abstract] [Full Text] [Related]
20. Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival. Burke MJ; Trotz B; Luo X; Baker KS; Weisdorf DJ; Wagner JE; Verneris MR Bone Marrow Transplant; 2009 Jan; 43(2):107-13. PubMed ID: 18776928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]